On December 1, 2025, the SUPPORT for Patients and Communities Reauthorization Act of 2025 was signed into law, extending critical federal substance use disorder (SUD) prevention, treatment, and recovery programs through fiscal year 2030. This bipartisan legislative achievement, passed overwhelmingly in the House and by unanimous consent in the Senate, reaffirms Congress’s commitment to combating the opioid and broader SUD crisis that continues to devastate communities nationwide.
The reauthorization preserves vital initiatives including SAMHSA’s Comprehensive Opioid Recovery Centers grants, the SUD Treatment and Recovery Loan Repayment Program, and targeted support for pregnant and postpartum individuals experiencing SUD — programs proven essential for expanding access to evidence-based care. By maintaining and strengthening these programs, the law supports communities on the front lines of addiction, promotes workforce development, and enhances coordinated prevention and recovery services.
However, as the article underscores, reauthorization is only the first step. Without full appropriations and robust agency capacity — particularly at SAMHSA and within Medicaid — these authorized programs may not deliver real-world impact. The challenges ahead include securing funding, rebuilding agency staffing after recent workforce losses, and safeguarding Medicaid’s role as the largest payer of behavioral health services.
This milestone should energize collaborative efforts among policymakers, providers, and communities to ensure these lifesaving investments translate into sustained, measurable progress in overdose prevention, treatment access, and long-term recovery support.
CLICK HERE to read the full article.